Amamangpan, Gena R.

HRN: 21-52-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/03/2022
07/03/2022
IV
240mg
Once
S/P NSVD With RMLE, Fever
Waiting Final Action 
07/03/2022
METRONIDAZOLE 500MG (TAB)
07/03/2022
07/09/2022
PO
500mg
TID
S/P NVD With RMLE; Fever
Waiting Final Action 
07/03/2022
CEFUROXIME 500MG (TAB)
07/03/2022
07/09/2022
PO
500mg
BID
S/P NSVD With RMLE, Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: